{
 "@context": "https://clearank.com/llms.txt",
 "@type": "clearank:AssetComparison",
 "url": "https://clearank.com/compare/acn-vs-ctsh/",
 "dataUrl": "https://clearank.com/compare/acn-vs-ctsh/data.json",
 "title": "ACN vs CTSH: Which Is the Better Buy? (2026)",
 "description": "ACN or CTSH? Compare ACN vs CTSH, daily AI-powered analysis with technical indicators, price targets, valuation, and a head-to-head verdict.",
 "headline": "Accenture PLC Class A vs Cognizant Technology Solutions",
 "published": "2026-06-18T09:18:58+00:00",
 "modified": "2026-09-15T17:32:03.8+00:00",
 "generated": "2026-09-16T10:58:50.918Z",
 "language": "en-US",
 "publisher": {
  "name": "CleaRank",
  "url": "https://clearank.com/"
 },
 "disclaimer": "Educational and informational only; not financial advice. AI-generated analysis reviewed by the CleaRank editorial team; prices delayed up to 15 minutes.",
 "assets": [
  {
   "ticker": "ACN",
   "dataUrl": "https://clearank.com/stock/accenture-acn/data.json"
  },
  {
   "ticker": "CTSH",
   "dataUrl": "https://clearank.com/stock/cognizant-ctsh/data.json"
  }
 ],
 "sections": [
  {
   "id": "verdict",
   "title": "Comparative Analysis",
   "text": [
    "Accenture (ACN) wins this head-to-head comparison against Cognizant (CTSH), primarily driven by its superior profitability and stronger return on equity. While both companies operate in the IT services sector and show positive revenue growth, Accenture demonstrates a more efficient business model and better capital utilization. CTSH offers a slightly lower valuation multiple, but ACN's financial strength and broader analyst support present a more compelling investment case at this juncture. Investors seeking stability and consistent performance may favor ACN, while those looking for a deeper value act might consider CTSH, though with caveats regarding its profitability metrics. The decision hinges on whether to prioritize strong profitability or a more attractive valuation multiple.",
    "Accenture's (ACN) superior profitability, evidenced by its higher net profit margin and significantly stronger return on equity, is the key differentiator against Cognizant (CTSH). This suggests ACN is a more efficient and financially strong company, capable of generating better returns for its shareholders from its operations and capital base. While CTSH offers a more attractive valuation multiple, ACN's demonstrated operational excellence and stronger financial health provide a more solid foundation for investment.",
    "The outlook for Accenture (ACN) appears cautiously optimistic, supported by its strong profitability and broad analyst coverage, though its current price trading above the median target warrants attention. A potential scenario involves ACN consolidating or experiencing a minor pullback before resuming an uptrend, especially if broader market conditions improve. Cognizant (CTSH) faces a more uncertain outlook, with its recent earnings miss and lower profitability metrics posing challenges. A positive scenario for CTSH would involve a strong rebound in earnings and a successful re-rating by the market, pushing it towards its 52-week high. However, a more likely scenario may involve continued underperformance relative to ACN unless significant operational improvements are demonstrated."
   ]
  },
  {
   "id": "price",
   "title": "Price Analysis Comparison"
  },
  {
   "id": "valuation",
   "title": "Valuation Metrics",
   "text": [
    "Accenture (ACN) trades at a Price-to-Earnings ratio of 15.22, which is higher than Cognizant's (CTSH) 12.88. This suggests that investors are willing to pay a premium for Accenture's earnings, potentially due to its perceived stability or growth prospects. CTSH, with its lower P/E, appears more attractively valued on a traditional earnings multiple basis. However, when considering market capitalization, ACN's $119.3 billion dwarfs CTSH's $28.9 billion, indicating a significantly larger scale of operations for Accenture. Both stocks are trading above their 50-day and 200-day moving averages, indicating positive price momentum, but ACN's price is closer to its 52-week high (291.09) than CTSH's (87.03), suggesting stronger recent performance for ACN relative to its yearly range. CTSH's price is currently closer to its 52-week low (37.08) than its high, indicating more room for upside if momentum continues."
   ],
   "tables": [
    {
     "caption": "Valuation Metrics: ACN vs CTSH",
     "columns": [
      "Metric",
      "ACN",
      "CTSH"
     ],
     "rows": [
      {
       "label": "P/E Ratio",
       "cells": [
        "15.22",
        "12.88"
       ]
      },
      {
       "label": "Market Cap",
       "cells": [
        "119.33B",
        "28.87B"
       ]
      },
      {
       "label": "Price/Sales",
       "cells": [
        "1.60",
        "1.25"
       ]
      },
      {
       "label": "Price/Book",
       "cells": [
        "3.66",
        "1.88"
       ]
      },
      {
       "label": "EV/EBITDA",
       "cells": [
        "8.68",
        "6.96"
       ]
      },
      {
       "label": "Dividend Yield",
       "cells": [
        "3.19%",
        "2.03%"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "profitability",
   "title": "Profitability & Efficiency",
   "text": [
    "Accenture (ACN) exhibits superior profitability compared to Cognizant (CTSH). ACN boasts a net profit margin of 10.66% and a return on equity of 24.41%, significantly outperforming CTSH's net profit margin of 10.26% and return on equity of 14.92%. Also, Accenture's return on assets at 10.9% is also higher than Cognizant's 10.74%. These metrics indicate that Accenture is more effective at converting revenue into profit and generating returns for its shareholders relative to its equity base and asset utilization. The higher return on equity for ACN is a key differentiator, suggesting better capital efficiency and management effectiveness."
   ],
   "tables": [
    {
     "caption": "Profitability & Efficiency: ACN vs CTSH",
     "columns": [
      "Metric",
      "ACN",
      "CTSH"
     ],
     "rows": [
      {
       "label": "Rev. Growth (Qtly)",
       "cells": [
        "5.60%",
        "4.50%"
       ]
      },
      {
       "label": "Profit Margin",
       "cells": [
        "10.66%",
        "10.26%"
       ]
      },
      {
       "label": "Return on Equity",
       "cells": [
        "24.41%",
        "14.92%"
       ]
      },
      {
       "label": "Return on Assets",
       "cells": [
        "10.90%",
        "10.74%"
       ]
      },
      {
       "label": "Debt/Equity",
       "cells": [
        "25.04",
        "14.48"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "earnings",
   "title": "Earnings Reality Check",
   "text": [
    "Last 5 Qs: ACN beat estimates 5x out of 5. Fell 3x after beats. (Sell the news?)",
    "Last 4 Qs: CTSH beat estimates 2x out of 4. Fell 2x after beats. (Sell the news?)"
   ]
  },
  {
   "id": "technicals",
   "title": "Technical Indicators",
   "text": [
    "Accenture (ACN) is showing strong technical signals, with its RSI at 58.69 and CCI at 123.71, indicating positive momentum without being overbought. Its Stochastic is at 99.50, suggesting it is in overbought territory, which in strong trend phases can persist. CTSH, on the other hand, has an RSI of 54.97 and a CCI of 45.65, indicating more neutral momentum. CTSH's Stochastic at 82.47 also suggests it is approaching overbought conditions. Both stocks are trading above their 50-day SMAs, with ACN at 168.21 and CTSH at 54.46, confirming an uptrend for both. However, ACN is trading below its 200-day SMA (201.11), while CTSH is also trading below its 200-day SMA (62.44), suggesting both are in intermediate-term downtrends or consolidating after prior rallies. ACN's MACD of 5.12 is higher than CTSH's 1.58, suggesting stronger upward momentum on the MACD indicator for Accenture."
   ],
   "tables": [
    {
     "caption": "Technical indicators: ACN vs CTSH",
     "columns": [
      "Indicator",
      "ACN",
      "CTSH"
     ],
     "rows": [
      {
       "label": "RSI (14)",
       "cells": [
        "58.69",
        "54.97"
       ]
      },
      {
       "label": "50-Day MA",
       "cells": [
        "$168.21",
        "$54.46"
       ]
      },
      {
       "label": "200-Day MA",
       "cells": [
        "$201.11",
        "$62.44"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "sentiment",
   "title": "AI Analyst Sentiment",
   "text": [
    "Analyst sentiment leans positive for both Accenture (ACN) and Cognizant (CTSH), but ACN garners slightly stronger backing. ACN has a 'Strong Buy' rating from 3 analysts and 11 'Buy' ratings, with a median target price of $185, which is below its current trading price of $197.43. CTSH has 3 'Strong Buy' ratings and 10 'Buy' ratings, with a median target price of $65.60, which is slightly above its current price of $64.10. The higher number of total analysts covering CTSH (29 vs 27 for ACN) and its median target being closer to its current price might suggest more immediate upside potential according to analysts. However, ACN's higher proportion of 'Strong Buy' and 'Buy' ratings relative to 'Hold' ratings indicates a more universally positive view from the analyst community."
   ]
  },
  {
   "id": "risk",
   "title": "Risk Stratification",
   "text": [
    "Accenture (ACN) faces risks including its current trading price being above the median analyst target, suggesting limited immediate upside according to some analysts, and its position below the 200-day moving average indicating potential for a trend reversal. Its high stochastic reading also signals potential for a short-term pullback. Cognizant (CTSH) faces risks related to its recent earnings miss and subsequent price drop, indicating potential investor concern about its near-term performance. Its price is also below the 200-day moving average, and while its median analyst target offers some upside, the overall analyst sentiment is slightly less bullish than for ACN. Both companies operate in a competitive IT services market, susceptible to economic downturns and shifts in technology spending."
   ],
   "tables": [
    {
     "caption": "Risk metrics: ACN vs CTSH",
     "columns": [
      "Metric",
      "ACN",
      "CTSH"
     ],
     "rows": [
      {
       "label": "Beta (Volatility) i",
       "cells": [
        "1.09",
        "0.83"
       ]
      },
      {
       "label": "Sharpe Ratio",
       "cells": [
        "-0.47",
        "-0.05"
       ]
      }
     ]
    }
   ]
  },
  {
   "id": "protips",
   "title": "Comparative ProTips",
   "lists": {
    "ProTips": [
     "ProTip 1: Consider ACN for its superior profitability and operational efficiency, which often translates to more stable long-term returns.",
     "ProTip 2: Monitor CTSH's ability to consistently meet earnings estimates; a pattern of misses could signal underlying business challenges.",
     "ProTip 3: Given both stocks are below their 200-day SMAs, use pullbacks as potential entry points, but be mindful of the overbought stochastic readings on ACN."
    ]
   }
  },
  {
   "id": "monte-carlo",
   "title": "Monte Carlo Projection (10yr)"
  },
  {
   "id": "trade-plans",
   "title": "Actionable Trade Plans",
   "text": [
    "Compare entry, exit, and risk management levels for both assets",
    "Volatility-Adjusted Stop Loss Calculated based on volatility and technical support levels."
   ],
   "facts": {
    "STOP LOSS": "$59.07"
   }
  },
  {
   "id": "faq",
   "title": "Frequently Asked Questions"
  },
  {
   "id": "people-also-watch",
   "title": "People Also Watch",
   "links": [
    {
     "text": "SCHD vs SCHG SCHD vs SCHG Comparison $34.34 +0.6448%",
     "url": "https://clearank.com/compare/schd-vs-schg/"
    },
    {
     "text": "VUG vs SCHG VUG vs SCHG Comparison $87.71 -0.3522%",
     "url": "https://clearank.com/compare/vug-vs-schg/"
    },
    {
     "text": "ELV vs HUM ELV vs HUM Comparison $419.17 -1.20%",
     "url": "https://clearank.com/compare/elv-vs-hum/"
    },
    {
     "text": "QQQ vs QQQM QQQ vs QQQM Comparison $705.45 -0.5260%",
     "url": "https://clearank.com/compare/qqq-vs-qqqm/"
    }
   ]
  }
 ],
 "faq": [
  {
   "question": "Which stock is a better buy, Accenture (ACN) or Cognizant (CTSH)?+",
   "answer": "Accenture (ACN) is the preferred buy due to its superior profitability and stronger return on equity, despite a higher valuation multiple. While Cognizant (CTSH) offers a lower P/E ratio, ACN's financial efficiency and broader analyst support present a more compelling case for long-term investment."
  },
  {
   "question": "What are the key risks for Accenture (ACN) versus Cognizant (CTSH)?+",
   "answer": "Accenture's primary risks include trading above its median analyst target and being below its 200-day SMA, suggesting potential for a trend reversal. Cognizant faces risks from its recent earnings miss, a similar position below its 200-day SMA, and slightly less favorable analyst sentiment."
  },
  {
   "question": "How do Accenture's (ACN) and Cognizant's (CTSH) valuations compare?+",
   "answer": "Cognizant (CTSH) trades at a lower P/E ratio (12.88) compared to Accenture (ACN) (15.22), suggesting CTSH is more attractively valued on this metric. However, ACN has a much larger market capitalization."
  },
  {
   "question": "How do the technical indicators stack up for ACN and CTSH?+",
   "answer": "Accenture (ACN) shows stronger momentum with a higher RSI (58.69 vs 54.97) and MACD (5.12 vs 1.58), though its stochastic is in overbought territory. Both are above their 50-day SMAs but below their 200-day SMAs."
  },
  {
   "question": "What do analysts say about Accenture (ACN) and Cognizant (CTSH)?+",
   "answer": "Analysts are generally positive on both, but Accenture (ACN) has a slightly higher proportion of 'Strong Buy' and 'Buy' ratings. CTSH's median target price is closer to its current trading level, suggesting more immediate upside potential according to some analysts."
  },
  {
   "question": "What is the dividend yield for ACN and CTSH?+",
   "answer": "Accenture (ACN) offers a dividend yield of approximately 3.19%, while Cognizant (CTSH) provides a yield of about 2.03%. ACN offers a higher income stream to investors."
  }
 ],
 "related": {
  "peopleAlsoWatch": [],
  "comparisons": [
   {
    "ticker": "SCHD vs SCHG",
    "name": "SCHD vs SCHG Comparison",
    "price": "$34.34",
    "change": "+0.6448%",
    "url": "https://clearank.com/compare/schd-vs-schg/"
   },
   {
    "ticker": "VUG vs SCHG",
    "name": "VUG vs SCHG Comparison",
    "price": "$87.71",
    "change": "-0.3522%",
    "url": "https://clearank.com/compare/vug-vs-schg/"
   },
   {
    "ticker": "ELV vs HUM",
    "name": "ELV vs HUM Comparison",
    "price": "$419.17",
    "change": "-1.20%",
    "url": "https://clearank.com/compare/elv-vs-hum/"
   },
   {
    "ticker": "QQQ vs QQQM",
    "name": "QQQ vs QQQM Comparison",
    "price": "$705.45",
    "change": "-0.5260%",
    "url": "https://clearank.com/compare/qqq-vs-qqqm/"
   }
  ],
  "Newly Tracked": [
   {
    "ticker": "FIS",
    "text": "Fidelity National Information Services, Inc.",
    "url": "https://clearank.com/stock/fis-stock-analysis/"
   },
   {
    "ticker": "EXC",
    "text": "Exelon Corp.",
    "url": "https://clearank.com/stock/exc-stock-analysis/"
   },
   {
    "ticker": "GWW",
    "text": "W.W. Grainger Inc.",
    "url": "https://clearank.com/stock/gww-stock-analysis/"
   },
   {
    "ticker": "CDE",
    "text": "Coeur Mining Inc.",
    "url": "https://clearank.com/stock/cde-stock-analysis/"
   },
   {
    "ticker": "CCI",
    "text": "Crown Castle Inc.",
    "url": "https://clearank.com/stock/cci-stock-analysis/"
   }
  ],
  "Top Movers (24h)": [
   {
    "ticker": "CAVA",
    "text": "↓ 8.93%",
    "url": "https://clearank.com/stock/cava-group-cava/"
   },
   {
    "ticker": "ARB/USD",
    "text": "↑ 19.42%",
    "url": "https://clearank.com/crypto/arbitrum-arb-usd/"
   },
   {
    "ticker": "INJ/USD",
    "text": "↓ 11.80%",
    "url": "https://clearank.com/crypto/injective-inj/"
   },
   {
    "ticker": "CRV/USD",
    "text": "↓ 11.53%",
    "url": "https://clearank.com/crypto/crv-usd-crypto-analysis/"
   },
   {
    "ticker": "CRCL",
    "text": "↓ 11.41%",
    "url": "https://clearank.com/stock/circle-internet-group-crcl/"
   }
  ]
 },
 "schema": [
  {
   "@context": "https://schema.org",
   "@graph": [
    {
     "@type": "Place",
     "@id": "https://clearank.com/#place",
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     }
    },
    {
     "@type": "Organization",
     "@id": "https://clearank.com/#organization",
     "name": "CleaRank",
     "alternateName": "CleaRank Financial AI",
     "url": "https://clearank.com",
     "description": "CleaRank is where retail traders research a trade and practice it before risking money. Its research arm, CleaRank Financial AI, publishes daily analysis, trade plans and 10-year projections for more than 1,000 stocks, ETFs, cryptocurrencies, forex pairs and commodities; each page is built from licensed market data, carries the date it was last updated and is reviewed under CleaRank's published editorial code. The CLEAR™ Score rates online brokers and prop firms on regulation, fees, platform reliability and verified trader experience. The research is free; CleaRank is paid for by subscriptions to its trading workbench (Pro $29 a month, Ultra $59 a month), which combines a live trading simulator, a trade journal that imports from broker history, an AI coach grounded in the trader's own trades, a portfolio generator, visualizer and backtester, a prop-firm challenge auditor and 22 trading calculators and scanners. Some free content contains partner links, which are disclosed and do not affect ratings.",
     "slogan": "Clear data. Honest analysis.",
     "logo": {
      "@type": "ImageObject",
      "@id": "https://clearank.com/#logo",
      "url": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "contentUrl": "https://clearank.com/media/uploads/2025/02/CleaRank-Logo-e1738621466340.jpg",
      "caption": "CleaRank",
      "inLanguage": "en-US",
      "width": "336",
      "height": "153"
     },
     "image": {
      "@id": "https://clearank.com/#logo"
     },
     "sameAs": [
      "https://x.com/CleaRank",
      "https://www.linkedin.com/company/clearank/",
      "https://www.youtube.com/@CleaRank",
      "https://t.me/clearank"
     ],
     "email": "info@clearank.com",
     "contactPoint": [
      {
       "@type": "ContactPoint",
       "contactType": "customer support",
       "email": "info@clearank.com",
       "url": "https://clearank.com/contact/",
       "availableLanguage": "en"
      }
     ],
     "address": {
      "@type": "PostalAddress",
      "streetAddress": "Beni Berman 2",
      "addressLocality": "Netanya",
      "addressRegion": "Center",
      "postalCode": "4249330",
      "addressCountry": "IL"
     },
     "location": {
      "@id": "https://clearank.com/#place"
     },
     "knowsAbout": [
      "stock analysis",
      "ETF analysis",
      "cryptocurrency analysis",
      "forex trading",
      "trading simulation",
      "trade journaling",
      "position sizing",
      "risk management",
      "prop firm challenges",
      "online broker regulation"
     ],
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "ethicsPolicy": "https://clearank.com/editorial-code/",
     "ownershipFundingInfo": "https://clearank.com/about-us/",
     "owns": {
      "@id": "https://clearank.com/#app"
     },
     "founder": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "WebSite",
     "@id": "https://clearank.com/#website",
     "url": "https://clearank.com",
     "name": "CleaRank",
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "inLanguage": "en-US"
    },
    {
     "@type": "ImageObject",
     "@id": "https://clearank.com/wp-content/uploads/2026/06/comparison-og-default.png",
     "url": "https://clearank.com/wp-content/uploads/2026/06/comparison-og-default.png",
     "width": "1200",
     "height": "630",
     "caption": "CleaRank head-to-head comparison",
     "inLanguage": "en-US"
    },
    {
     "@type": "BreadcrumbList",
     "@id": "https://clearank.com/compare/acn-vs-ctsh/#breadcrumb",
     "itemListElement": [
      {
       "@type": "ListItem",
       "position": "1",
       "item": {
        "@id": "https://clearank.com",
        "name": "Home"
       }
      },
      {
       "@type": "ListItem",
       "position": "2",
       "item": {
        "@id": "https://clearank.com/compare/acn-vs-ctsh/",
        "name": "ACN vs CTSH Comparison"
       }
      }
     ]
    },
    {
     "@type": "WebPage",
     "@id": "https://clearank.com/compare/acn-vs-ctsh/#webpage",
     "url": "https://clearank.com/compare/acn-vs-ctsh/",
     "name": "ACN vs CTSH: Which Is the Better Buy? (2026)",
     "datePublished": "2026-06-18T09:18:58+00:00",
     "dateModified": "2026-09-15T17:32:03+00:00",
     "isPartOf": {
      "@id": "https://clearank.com/#website"
     },
     "primaryImageOfPage": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/comparison-og-default.png"
     },
     "inLanguage": "en-US",
     "breadcrumb": {
      "@id": "https://clearank.com/compare/acn-vs-ctsh/#breadcrumb"
     },
     "reviewedBy": {
      "@id": "https://clearank.com/writer/shaundavidb/#person"
     }
    },
    {
     "@type": "Person",
     "@id": "https://clearank.com/writer/shaundavidb/#person",
     "name": "Shaun David",
     "jobTitle": "Co-Founder",
     "url": "https://clearank.com/writer/shaundavidb/",
     "image": "https://clearank.com/media/uploads/2025/01/Shaun-David-Author-Image-.jpeg",
     "sameAs": [
      "https://www.linkedin.com/in/shaun-david-697b5817a/"
     ],
     "worksFor": {
      "@id": "https://clearank.com/#organization"
     }
    },
    {
     "@type": "Article",
     "@id": "https://clearank.com/compare/acn-vs-ctsh/#richSnippet",
     "headline": "ACN vs CTSH: Which Is the Better Buy? (2026)",
     "name": "ACN vs CTSH: Which Is the Better Buy? (2026)",
     "description": "ACN or CTSH? Compare ACN vs CTSH, daily AI-powered analysis with technical indicators, price targets, valuation, and a head-to-head verdict.",
     "datePublished": "2026-06-18T09:18:58+00:00",
     "dateModified": "2026-09-15T17:32:03+00:00",
     "author": {
      "@id": "https://clearank.com/#organization"
     },
     "publisher": {
      "@id": "https://clearank.com/#organization"
     },
     "publishingPrinciples": "https://clearank.com/editorial-code/",
     "isPartOf": {
      "@id": "https://clearank.com/compare/acn-vs-ctsh/#webpage"
     },
     "image": {
      "@id": "https://clearank.com/wp-content/uploads/2026/06/comparison-og-default.png"
     },
     "inLanguage": "en-US",
     "mainEntityOfPage": {
      "@id": "https://clearank.com/compare/acn-vs-ctsh/#webpage"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "ItemList",
   "name": "ACN vs CTSH Comparison",
   "url": "https://clearank.com/compare/acn-vs-ctsh/",
   "numberOfItems": 2,
   "itemListElement": [
    {
     "@type": "ListItem",
     "position": 1,
     "item": {
      "@type": "FinancialProduct",
      "name": "Accenture (ACN)",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "ACN"
       }
      ],
      "description": "AI-driven analysis of Accenture (ACN) - price targets, valuation, technicals.",
      "url": "https://clearank.com/stock/accenture-acn/"
     }
    },
    {
     "@type": "ListItem",
     "position": 2,
     "item": {
      "@type": "FinancialProduct",
      "name": "Cognizant Technology Solutions Corp. (CTSH)",
      "identifier": [
       {
        "@type": "PropertyValue",
        "propertyID": "tickerSymbol",
        "value": "CTSH"
       }
      ],
      "description": "AI-driven analysis of Cognizant Technology Solutions Corp. (CTSH) - price targets, valuation, technicals.",
      "url": "https://clearank.com/stock/cognizant-ctsh/"
     }
    }
   ]
  },
  {
   "@context": "https://schema.org",
   "@type": "FAQPage",
   "mainEntity": [
    {
     "@type": "Question",
     "name": "Which stock is a better buy, Accenture (ACN) or Cognizant (CTSH)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Accenture (ACN) is the preferred buy due to its superior profitability and stronger return on equity, despite a higher valuation multiple. While Cognizant (CTSH) offers a lower P/E ratio, ACN's financial efficiency and broader analyst support present a more compelling case for long-term investment."
     }
    },
    {
     "@type": "Question",
     "name": "What are the key risks for Accenture (ACN) versus Cognizant (CTSH)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Accenture's primary risks include trading above its median analyst target and being below its 200-day SMA, suggesting potential for a trend reversal. Cognizant faces risks from its recent earnings miss, a similar position below its 200-day SMA, and slightly less favorable analyst sentiment."
     }
    },
    {
     "@type": "Question",
     "name": "How do Accenture's (ACN) and Cognizant's (CTSH) valuations compare?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Cognizant (CTSH) trades at a lower P/E ratio (12.88) compared to Accenture (ACN) (15.22), suggesting CTSH is more attractively valued on this metric. However, ACN has a much larger market capitalization."
     }
    },
    {
     "@type": "Question",
     "name": "How do the technical indicators stack up for ACN and CTSH?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Accenture (ACN) shows stronger momentum with a higher RSI (58.69 vs 54.97) and MACD (5.12 vs 1.58), though its stochastic is in overbought territory. Both are above their 50-day SMAs but below their 200-day SMAs."
     }
    },
    {
     "@type": "Question",
     "name": "What do analysts say about Accenture (ACN) and Cognizant (CTSH)?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Analysts are generally positive on both, but Accenture (ACN) has a slightly higher proportion of 'Strong Buy' and 'Buy' ratings. CTSH's median target price is closer to its current trading level, suggesting more immediate upside potential according to some analysts."
     }
    },
    {
     "@type": "Question",
     "name": "What is the dividend yield for ACN and CTSH?",
     "acceptedAnswer": {
      "@type": "Answer",
      "text": "Accenture (ACN) offers a dividend yield of approximately 3.19%, while Cognizant (CTSH) provides a yield of about 2.03%. ACN offers a higher income stream to investors."
     }
    }
   ]
  }
 ]
}